Amanote Research

Amanote Research

    RegisterSign In

Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease?

PLoS ONE - United States
doi 10.1371/journal.pone.0041842
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

July 23, 2012

Authors
Linda J. CobiacAnne MagnusStephen LimJan J. BarendregtRob CarterTheo Vos
Publisher

Public Library of Science (PLoS)


Related search

Statins for Primary Prevention of Cardiovascular Disease

British Medical Journal
Medicine
2019English

Multiple Risk Factor Interventions for Primary Prevention of Cardiovascular Disease in Low- And Middle-Income Countries

2014English

Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes Mellitus

Nature Reviews Endocrinology
EndocrinologyMetabolismDiabetes
2010English

Risk Scoring for the Primary Prevention of Cardiovascular Disease

2015English

Green and Black Tea for the Primary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2013English

Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease

American Journal of Medicine
Medicine
2016English

Systematic Versus Opportunistic Risk Assessment for the Primary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2016English

Omega-6 Fats for the Primary and Secondary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2018English

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy